1. European Medicines Agency Abasaglar Insulin Glargine http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/002835/WC500175384.pdf
2. Development and regulation of biosimilars: current status and future challenges;Tsiftsoglou;BioDrugs,2013
3. European Medicines Agency Biosimilars http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=WC0b01ac058001d125&searchTab=searchByAuthType&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keyword=Enter+keywords&searchType=name&taxonomyPath=&treeNumber=&searchGenericType=biosimilars&genericsKeywordSearch=Submit
4. Biosimilar insulins: guidance for data interpretation by clinicians and users;Heinemann;Diabetes Obes Metab,2015
5. European Medicines Agency Guideline on Similar Biological Medicinal Products http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/10/WC500176768.pdf